February 23, 2018

2Morrow Launches New Digital Therapeutic Aimed at Managing Chronic Pain with a Non-Opioid, Behavioral Approach  | 2Morrow

January 31, 2018

Cardea 20/20 ECG helping provide in-dept heart testing to student athletes | KPRC2

October 16, 2017

Serial entrepreneur, angel investor, philanthropist, author and CEO of Bizzultz May McCarthy explains how intuition will help you achieve financial freedom. | Entrepreneur

April 5, 2017

Monitor Mask has finalized an OEM distribution agreement with Salter Labs. The CapnoVue face masks are now listed on two GPO contracts. Monitor Mask welcomed Mark Strmac as the Eastern Regional Sales Director and engaged the services of Sherrill Small as a marketing consultant.

March 27, 2017

2Morrow Inc. Wins MedTech Innovator Seattle Pitch | Life Science Washington Member News

March 5, 2017


February 28, 2017

WINGS and MedTech Innovator, sponsored in part by Life Science Washington will be holding a pitch competition March 15 in Seattle at the Agora Conference Center. Also, Bill Waller gives an update about WINGS Winners at AdvaMed’s 2016 Innovation Showcase.

February 13, 2017

WINGS and MedTech Innovator, sponsored in part by Life Science Washington, will be holding a pitch competition March 15, 2017 at the Agora Conference Center located at 1551 Eastlake Ave E.

January 19, 2017

MedTech Innovator is the industry’s nonprofit global competition and accelerator. In 2017, MedTech Innovator will award over $500K in cash prizes. Early to mid-stage medical device, diagnostic, and digital health companies are encouraged to apply at https://medtechinnovator.org/apply by the Feb. 28 deadline.

December 6, 2016

Accelerating BioPharma with powerful software tools on the cloud.

October 20, 2016
October 6, 2016

2Morrow named one of 15 finalists of MedCity’s patient engagement startup contest. A reader’s choice winner will be selected via poll. Separately, a judging panel will select winners. These results will be announced later in October. | MedCity News

July 28, 2016

H-Source was recently listed on the Toronto Stock Exchange. They have 200+ hospitals under contract with 150 on-boarded, and are on track to have 350+ by year end. They have four prominent mutual funds among their investors and they are creating value for hospitals as well as good jobs in Eastern Washington. | H-Source

May 6, 2016

Cardiac Insight raises $2.5M to fund sales push for CardeaScreen.

May 5, 2016

Chad Robins, CEO Adaptive Technologies, was selected as a finalist for the EY Entrepreneur Of The Year® 2016 Award in the Pacific Northwest.

May 4, 2016

Impel NeuroPharma was awarded a $1.5M Phase II SBIR Grant from NIMH to further develop pre-clinical POD devices.

May 3, 2016

Cyrus Biotechnology is turning Rosetta into a commercial-grade, cloud computing platform. David Baker presented at the EXOME Life Science Disruptors conference by Xconomy.

April 27, 2016

2Morrow raises $500k to grow user base.

April 18, 2016

Seattle-based PotaVida, which designs bags that purify water with sunlight and collect data on how the bag is used, will have a big test in mid-May.

April 12, 2016

Dr. Jonathan Bricker, Fred Hutchinson Cancer Research Center, has teamed up with Dr. Feng Cheng, Tsinghua University in Beijing, to develop Smart Quit China.

April 5, 2016

OtoNexus was selected as the InnovateHer Seattle 2016 winner out of 8 finalists. OtoNexus was awarded $5k of developer services provided by Mr. PK Samal of Startup Fair.

March 16, 2016

In a twist on the traditional smoking cessation model, GlaxoSmithKline ($GSK) is pairing with 2morrow’s SmartQuit app to supply patches to smokers who have already completed the app plan.

March 15, 2016

Adaptive Biotechnologies announces Diego Miralle as the president of the new division: Adaptive Therapeutics.

February 12, 2016

H-Source is now trading under the symbol HSCHF on the OTCQB in the United States of America.

February 5, 2016

Valant Medical Solution’s Valant Platform featured as a mental health technology tool to help receive facilities funding.



January 26, 2016

Centurion Medical Products has acquired NuvoMed, Inc. and the DisImpactor (R).

January 15, 2016

PIA adds toSense and Erasmus University to their Core Lab business.

December 18, 2015

JW Beard, CTO of Monitor Mask, and Brandon Masterson, CEO of 2Morrow, were celebrated at the 2015 Seattle Health Innovators award ceremony as Seattle Health Innovators.

December 10, 2015

Monitor Mask completed the initial close for its Series A funding round.

October 8, 2015

Cyrus Biotechnology licenses biochemistry software to Indiana University Research and Technology Corporation (IURTC) at Indiana University to commercialize SparksX software.

June 27, 2015

Monitor Mask, Inc. has released the FDA-cleared CapnoVue M1 face mask for improved CO2 monitoring. This mask will provide reliable and consistent CO2 monitoring during sedation anesthesia.

June 20, 2015

FHCRC scientist Jonathan Bricker awarded 5 year, $3.1M grant from the National Cancer Institute to update SmartQuit.

June 16, 2015

Cyrus Biotechnology’s SaaS product, Cyrus Bench, can rapidly sort millions of virtual proteins to help speed up drug design.

May 25, 2015

Cyrus Biotechnology is excited to announce their licensing of Rosetta software from the University of Washington and their initial funding.

March 4, 2015

With support from the Life Sciences Discovery Fund (LSDF), SmartQuit is starting its second clinical trial to evaluate effectiveness among employers.

October 2, 2014

2Morrow’s SmartQuit was pitted again NCI’s QuitGuide app in a double-blind randomized study. SmartQuit users were found to open the app more. SmartQuit users had a 13% quit rate compared to 8% for QuitGuide.

June 3, 2014

The M1 Capnography Mask by Monitor Mask Inc., has obtained US FDA 510(k) premarket notification clearance.

April 29, 2014

2Morrow announces licensing agreement with the Fred Hutchinson Cancer Research Center to commercialization The SmartQuit app.

April 22, 2014

2Morrow awarded $250k grant from LSDF for smoking cessation app.